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Abstract
The continuing threat of antimicrobial resistance presents a considerable
challenge to researchers to develop novel strategies ensuring that bacterial
infections remain treatable. Many plant extracts have been shown to have
antibacterial properties and could potentially be combined with other
antibacterial agents to create more effective formulations. In this study, the
antibacterial activity of three plant extracts and virulent bacteriophages have
been assessed as individual components and in combination. When assessed
with a modified suspension test, these plant extracts also exhibit antiviral
activity at bacterial inhibitory concentrations. Hence, to investigate any
potential additive effects between the extracts and virulent phages, the extracts
were tested at subantiviral concentrations. Phages alone and in combination
with plant extracts significantly reduced (P < 005) the bacterial concentration
compared to untreated and extract treated controls up to 6 h (2–3log10), but
this reduction did not extend to 24 h. In most cases, the phage and extract
combinations did not significantly reduce bacterial content compared to
phages alone. Additionally, there was little impact on the ability of the phages
to reproduce within their bacterial hosts. To our knowledge, this study
represents the first of its kind, in which antimicrobial plant extracts have been
combined with virulent phages and has highlighted the necessity for plant
extracts to be functionally characterized prior to the design of combinatorial
therapies.
Introduction
The potential for a future in which bacterial infections
become untreatable is undeniable, with a number of
bacterial infections failing to respond to drugs of last
resort or antibiotic combination therapy (Fifer et al.
2016; Bi et al. 2017). While this is due not only to an
increase in the level and type of resistance that exists
(Zhu et al. 2013; Oz et al. 2014), the overuse and mis-
use of antibiotics in both human and veterinary applica-
tions cannot be understated (Berendonk et al. 2015;
Meek et al. 2015; Fleming-Dutra et al. 2016) and has
shifted focus towards new strategies for combatting mul-
ti-resistant infections, including reducing antibiotic con-
sumption (Sabuncu et al. 2009) and the development of
new therapies (Brown and Wright 2016). Both bacterio-
phages and plant extracts are amongst those being inves-
tigated either as individual therapies (Bonifacio et al.
2014; Semler et al. 2014; Takemura-Uchiyama et al.
2014) or as adjuvants to conventional antibiotics (Coul-
ter et al. 2014; Cushnie et al. 2014; Kamal and Dennis
2015).
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A number of strategies are being pursued to reduce
antibiotic resistance levels, including the development of
new types of therapy and reduction of antibiotic con-
sumption. Although combinatorial therapy between
antibiotics and phages has been shown to be successful
in vitro, and furthermore against resistant phenotypes
(Comeau et al. 2007; Torres-Barcelo et al. 2016), it is per-
haps counteractive to employ at the same time as trying
to reduce overall consumption of antibiotics, particularly
in veterinary applications where antibiotic resistance is a
major issue (Allen 2014; Van Boeckel et al. 2015). As
such, combinations of naturally antimicrobial plant
extracts with virulent phages could potentially address
such issues.
In the current study, the antimicrobial potential of
subinhibitory concentrations of three antimicrobial plant
extracts in combination with virulent phages has been
investigated.
The plant extracts were derived from Stephania suber-
osa roots (SSE, Menispermaceae), Oroxylum indicum
fruits (OIE, Bignoniaceae) and Boesenbergia rotunda rhi-
zomes (BRE, Zingiberaceae), all used in traditional Asian
Medicine. The virulent bacteriophages SU16 (Myoviridae)
and SU27 (Siphoviridae) were isolated from wastewater
in 2010 and have been previously shown to be able to
infect 16 and 4 strains of Eshcherichia coli at high or
moderate efficiency of plating, respectively (Khan Mirzaei
and Nilsson 2015).
Results and discussion
MIC/MBC determination and anti-phage activity of plant
extracts
Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) determination showed
that both host bacterial strains (ECOR16 and ECOR27
from the E. coli standard reference collection; ECOR;
Ochman and Selander 1984) were inhibited by the bulk
plant extracts at the same inhibitory concentrations
(Table 1). When the bulk extracts were tested for antiviral
properties, all three extracts produced a statistically signif-
icant reduction (approx. 05–2 log10 PFU per ml;
P < 005; Fig. 1) of phage SU16 at MIC concentrations.
There was a significant difference in the susceptibility of
the two phages, SU16 and SU27, when tested against at
multiple concentrations of BRE and OIE (100-1% MIC;
P < 005; Fig. 1), while SSE showed no significant differ-
ence between the two phages at concentrations of 10%
MIC or lower (P > 005; Fig. 1). Due to the differences
in anti-phage activity exhibited by the different com-
pounds, the concentration of the plant extracts was opti-
mized on a phage+compound basis for time kill analyses.
Table 1 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of extracts (mg ml1) used in the current
investigation to bacterial host strains
Compound/Extract
Bacterial strain
ECOR16 ECOR27
MIC MBC MIC MBC
SSE 4  0 16  0 4  0 16  0
OIE 1333  462 4267  1848 1333  462 4267  1848
BRE 16  0 32  0 16  0 32  0
Data are the mean of three replicates  SD. Stephania suberosa root (SSE), Oroxylum indicum fruit (OIE), and Boesenbergia rotunda rhizome
(BRE) extracts.
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Figure 1 Antiviral activity of plant extracts against bacteriophages
SU16 and SU27 after 24 h exposure. ( ) SU16 + Boesenbergia
rotunda rhizomes (BRE); ( ) SU16 + Oroxylum indicum fruits (OIE);
( ) SU16 + Stephania suberosa roots (SSE); ( ) SU27 + BRE; ( )
SU27 + OIE; (h) SU27 + SSE. Data are the mean of three replicates
SD. The minimum inhibitory concentration (MIC) of extract concen-
trations were 16 mg ml1 for BRE and OIE and 4 mg ml1 for SSE
against both bacterial host strains. *Indicates selected concentration
that shows nonsignificant difference to the untreated control
(P > 005).
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Combined activity of bacteriophages and bulk plant
extracts
vTwo bacteriophages (one Myoviridae, SU16 and one
Siphoviridae, SU27) which infect E. coli were investigated
for their antibacterial activity when combined with bulk
plant extracts with known antimicrobial properties. The
phages were only tested against the strains from which they
were originally isolated, but have been previously shown to
be active against several E. coli strains (Khan Mirzaei and
Nilsson 2015). Overall, the combination of bulk plant
extracts and bacteriophages exhibited no significant differ-
ence in antibacterial activity at 24 h when compared to the
untreated control or the individual components (P > 005;
Figs 2 and 3). However, both phage only and phage with
extract significantly reduced bacterial content in all cases
for up to 6 h compared to the untreated and extract only
controls (P < 005; Figs 2 and 3), which suggests that the
reduction was primarily driven by the phage component.
No phage SU16 + extract-treated samples showed signifi-
cant differences compared to the phage only samples
(P > 005; Fig. 2). In the case of phage SU27 and extract
treated samples, a significant additive effect could be seen
when BRE (up to 4 h) and OIE (up to 8 h) extracts were
added (Fig. 3a,b). Interestingly, a noticeable shift in the
bacterial growth could be observed in the BRE and OIE
extracts only compared to control which may be responsi-
ble for this additive effect. In addition, a significant reduc-
tion (P < 005) in phage titre for the OIE-treated sample
was observed at 2 to 8 h (Fig. 3b).
The concentrations of extracts tested in the current inves-
tigation were chosen to be subinhibitory to bacterial growth
and also of limited toxicity to phages. While this appears to
be the case with phage SU16 and ECOR16 (Fig. 2), with
modest and often statistically insignificant differences
(P > 005) in phage and BRE or OIE extract titre compared
to nonextract containing controls (Fig. 2a,b), there are dif-
ferences in susceptibilities when used in concentration with
SU27, most notably for OIE and SSE phage titres.
The combination of phages with adjuvant components is
a currently understudied topic, with great focus being
placed on the combination of phages and conventional
antibiotics (Chaudhry et al. 2017; Oechslin et al. 2017;
Scanlan et al. 2017) and purified phage cocktails (Gun-
dogdu et al. 2016; Regeimbal et al. 2016; Yen et al. 2017).
However, in order to further develop phages as antimicro-
bial agents, it is necessary to investigate the impact of more
complex formulations which include additional active and
excipient components (Abedon 2017). The current proof of
concept study has highlighted the variation which can be
introduced by including such additional components, par-
ticularly when they are poorly characterized bulk com-
pounds derived from natural products.
Materials and methods
All chemicals and reagents were obtained from either
Sigma Aldrich (Stockholm, Sweden) or VWR (Stockholm,
Sweden) and of general laboratory grade unless otherwise
stated in the text.
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Figure 2 Activity of phage SU16 in combination with different plant
extracts against ECOR16. (a) Boesenbergia rotunda rhizomes (BRE)
(16 lg ml1); (b) Oroxylum indicum fruits (OIE) (16 lg ml1); (c)
Stephania suberosa roots (SSE) (400 lg ml1). ( ) Untreated control;
( ) Extract Only; ( ) Phage Only; (h) Extract and phage. The
mean  SD for three replicates are illustrated. Means sharing the
same superscript at the same time are not significantly different from
each other (Tukey’s HSD test, P < 005). Lines indicate phage counts.
( ) phage only; ( ) Extract and phage. *Indicates significant differ-
ence to the phage at the same time (P < 005).
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Plant extracts
Fresh samples of SSE, OIE and BRE were obtained locally
from Nakhon Ratchasima province, Thailand. Samples
were cut into small pieces, dried for 2 days at 40°C and
ground into a coarse powder with a mechanical grinder.
Crude antimicrobial mixtures were extracted from 500 g
of powdered samples with soxhlation extraction in 2 l of
ethanol for 8 h. Extracts were passed through Whatman
number 1 filter paper to remove large debris and the sol-
vent removed by rotatory evaporation under reduced
pressure at 50°C. The remaining sample was lyophilized
to obtain dried extracts. Extracts were stored at 20°C
until required and suspended in PBS (for SSE) or PBS
with 5% DMSO (for BRE and OIE).
Bacteriophage and bacterial strains
Escherichia coli strains ECOR16 and ECOR27 were
obtained from the E. coli standard reference collection
(ECOR; Ochman and Selander 1984). These strains are
the hosts on which phages SU16 and SU27 were originally
isolated. Working stocks were produced from 80°C
glycerol stocks and maintained on lysogeny agar (LA)
plates stored at 4°C. ECOR16 and ECOR27 were rou-
tinely cultured in lysogeny broth (LB) at 37°C overnight
with shaking at 150 rev min1. Prior to use, suspensions
were centrifuged at 3864g for 15 min, the supernatant
discarded and the pellet suspended in 10 ml phosphate
buffered saline (PBS) and further diluted in PBS to con-
tain 1–5 9 108 CFU per ml.
Previously characterized phages SU16 and SU27 (Khan
Mirzaei and Nilsson 2015) were obtained from Stockholm
University stocks stored at 80°C in glycerol. Phages
were cultured in 10 ml lysogeny broth (LB) using the
appropriate bacterial strain (100 ll inoculum of overnight
culture) as the regular host at 37°C overnight with shak-
ing. Following incubation, suspensions were centrifuged
at 3864g for 15 min at 4°C and passed through 045 and
02 lm syringe filters. Phage suspensions were enumer-
ated, using the agar overlay method (Adams 1959) and
stored at 4°C until required. Prior to use, phages were
diluted in PBS to contain 1–3 9 108 PFU per ml.
MIC/MBC determination and activity of extracts against
phage
The minimum inhibitory concentration and MBC of
plant extracts were determined against ECOR16 and
ECOR27 using a modified broth method (Clinical and
Laboratory Standards Institute 2014). In brief, standard-
ized bacterial suspensions were diluted 1 : 100 in double
strength LB (dsLB) and the bacterial content determined
by the drop count method (Miles et al. 1938). To tripli-
cate wells of the first row of a 96-well microtitre plate,
200 ll of plant extract was added. A 100 ll aliquot was
removed and serially diluted 1 : 2 in PBS over the
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Figure 3 Activity of phage SU27 in combination with different
plant extracts against ECOR27. (a) Boesenbergia rotunda rhizomes
(BRE) (16 mg ml1); (b) Oroxylum indicum fruits (OIE) (16 mg ml1);
(c) Stephania suberosa roots (SSE) (400 lg ml1). ( ) Untreated
control; ( ) Extract Only; ( ) Phage Only; (h) Extract and
phage. The mean  SD for three replicates are illustrated. Means
sharing the same superscript at the same time are not significantly
different from each other (Tukey’s HSD test, P < 005). Lines indi-
cate phage counts. ( ) phage only; ( ) Extract and phage.
*Indicates significant difference to the phage at the same time
(P < 005).
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remainder of the plate. To each well, 100 ll of the diluted
bacterial suspension was added and the plate incubated at
37°C overnight. The MIC value was determined to be the
lowest concentration where no visible growth could be
observed. MBC was determined by spreading 100 ll of
suspension from wells showing no visible growth over the
surface of pre-prepared LA plates which were then incu-
bated at 37°C overnight. The MBC value was determined
to be the lowest concentration where no visible growth
could be observed.
The activity of plant extracts against phages SU16 and
SU27 was assessed using a modified suspension test assay
(Pinto et al. 2010). In brief, 1 ml of standardized phage
suspension was added to 9 ml plant extract at different
concentrations (100, 10, and 1% of MIC) and incubated
for 24 h at 37°C). Extracts which maintained significant
antiviral activity at 1% MIC were further diluted as neces-
sary. After 24 h incubation, 100 ll aliquots were removed
and added to 99 ml PBS. Suspensions were then serially
diluted in PBS and the phage content determined, using
the agar overlay method (Adams 1959).
Combined antibacterial activity of phage+extract
combinations
Twenty-five milliliter of dsLB was added to 5 ml of
extracts in PBS (or PBS with 5% (v/v) DMSO where
appropriate), 5 ml of standardised phage suspension and
5 ml standardised bacterial suspension. The total volume
was then increased with PBS to a final volume of 50 ml
and flasks incubated at 37°C with shaking at 150 rpm
min1. At defined time points (t = 2, 4, 6, 8 and 24 h)
1 ml aliquots were removed from each flask, and 1 ml of
fresh LB was added to each flask to maintain volume. For
phage containing samples, a 500 ll aliquot was added to
50 ll chloroform, vortexed and phage content determined,
using the agar overlay method (Adams 1959). One hun-
dred ll of the original sample was then serially diluted
1 : 10 in PBS and bacterial content determined by spread-
ing 100 ll of each dilution over the surface of duplicate
LA plates. For nonphage containing samples, the bacterial
content was determined using the drop count method
(Miles et al. 1938). Plates were incubated overnight at
37°C and the CFU per ml or PFU per ml content deter-
mined. Controls containing PBS/PBS+DMSO (untreated)
or phage only (no extracts) were also performed.
Statistical analysis
All experiments were performed in triplicate unless stated
in the text. Data were expressed as the mean  standard
deviation. Significant differences in the bacterial viable
count among each of treated groups at the same time
were analysed by one-way ANOVA followed by Tukey’s
HSD post hoc test. The P < 005 was considered as the
statistically significant difference. Also, the significant dif-
ferences between each tested group and the control were
determined, using independent T-tests at P < 005.
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